HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA

Botulinum Neurotoxin

Botulinum Neurotoxin

Botulinum neurotoxin (BoNT) is a toxin which is produced by the bacteria Clostridium botulinum. It belongs to the BoNT/A group of clostridial toxin family and is among the most powerful and deadly toxins known to mankind. BoNT acts by blocking the release of the neurotransmitter acetylcholine from presynaptic nerve terminals, thus causing flaccid paralysis of the muscle. BoNT has been used for therapeutic purposes as a muscle relaxant since the end of the last century. It is used to treat a variety of medical conditions such as cervical dystonia, blepharospasm, strabismus, and facial wrinkles. BoNT injections have become increasingly popular due to their success in reducing the appearance of wrinkles and treating muscle spasms. BoNT is available in various forms and formulations. Its potential medical applications are expanding from its traditional therapeutic uses to new areas in clinical research such as drug delivery systems, gene therapy, and neuroprotection. BoNT has also been proposed as a biological weapon due to its high toxicity and persistence in inhaled air. BoNT is a potent toxin and can be fatal in large doses. Moreover, it is resistant to traditional antiviral and antimicrobial therapies. A variety of techniques are used to protect against BoNT exposure including immunization, physical barriers, and a combination of both. Vaccines are available to provide protection from some of the BoNT serotypes. In conclusion, BoNT is a highly potent toxin with great potential in the medical field and has been used for a variety of medical conditions such as neurological disorders and wrinkles. Of course, it must be handled with extreme caution due to its immense toxicity and potential to be used as a biological weapon. Vaccines are available to provide protection from some of the BoNT serotypes and other measures can be taken to protect against exposure.

Committee Members
Speaker at Neuroscience Conference - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia
Speaker at Neurology and Brain Disorders - Joe Sam Robinson

Joe Sam Robinson

Mercer University, United States
Speaker at Neurology Conferences - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
INBC 2025 Speakers
Speaker at Brain Disorders Conference - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Neuroscience Conference - Roger H Coletti

Roger H Coletti

Interventional Health, PA, United States
Speaker at Neuroscience Conference - Stephen Grossberg

Stephen Grossberg

Boston University, United States
Speaker at Brain Disorders Conference - George Diaz

George Diaz

Memorial Healthcare Systems, United States

Submit your abstract Today

Watsapp